You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Stanton v. Merck & Co. (In re Zostavax (Zoster Vaccine Live) Prods. Liab. Litig.)

Citation: 358 F. Supp. 3d 418Docket: MDL No. 2848; CIVIL ACTION NO. 18-20057; CIVIL ACTION NO. 18-20059

Court: District Court, E.D. Pennsylvania; January 6, 2019; Federal District Court

Narrative Opinion Summary

In this case, two plaintiffs filed lawsuits against Merck & Co., Inc. and McKesson Corp. regarding personal injuries allegedly caused by the Zostavax vaccine. The cases, initially filed in Florida state court, were removed to the federal court based on diversity jurisdiction. Merck moved to dismiss based on lack of personal jurisdiction, while McKesson did not file a similar motion. The court found that the plaintiffs failed to establish personal jurisdiction over Merck under Florida's long-arm statute, as the injuries occurred outside of Florida. Furthermore, the court determined that exercising jurisdiction would violate the Due Process Clause of the Fourteenth Amendment, given the absence of Merck’s relevant activities in Florida. The court also addressed the plaintiffs' request to transfer the cases under 28 U.S.C. § 1631, denying the motion due to a lack of authority as per MDL panel decisions and the precedent set by Lexecon v. Millberg Weiss. Ultimately, the court dismissed the actions against Merck without prejudice due to lack of personal jurisdiction, leaving open the possibility for the plaintiffs to refile in a proper forum. The decision underscores the complexities of personal jurisdiction in multidistrict litigation and the constraints on transferring cases under federal statutes.

Legal Issues Addressed

Due Process Clause and Personal Jurisdiction

Application: The court held that asserting personal jurisdiction over Merck in Florida would violate the Due Process Clause of the Fourteenth Amendment since the injuries did not arise from Merck's activities in Florida.

Reasoning: Merck lacks personal jurisdiction in Florida regarding the plaintiffs' injuries, as the injuries did not arise from Merck's activities in the state. The focus must be on the location of the injury rather than where it was diagnosed.

Multidistrict Litigation and Transferor Court Authority

Application: The court concluded that it did not have the authority to transfer cases within multidistrict litigation to itself or other districts, following Lexecon v. Millberg Weiss.

Reasoning: According to Lexecon v. Millberg Weiss, a transferee court in multidistrict litigation cannot transfer actions to itself under 28 U.S.C. § 1404(a).

Personal Jurisdiction Under Florida's Long-Arm Statute

Application: The court determined that the plaintiffs did not establish personal jurisdiction over Merck under Florida's long-arm statute, as the injuries did not occur in Florida.

Reasoning: Plaintiffs, residents of Florida, allege tortious acts related to the faulty Zostavax vaccine occurred in Massachusetts and Connecticut, not in Florida. They do not base their claims on Merck's general business activities in Florida.

Transfer of Cases for Want of Jurisdiction

Application: The court denied the plaintiffs' motions to transfer their cases under 28 U.S.C. § 1631, citing a lack of authority to do so per recent MDL panel decisions.

Reasoning: The plaintiffs propose transferring the case to a proper forum under 28 U.S.C. § 1631 if personal jurisdiction is denied. This statute allows for the transfer of cases lacking jurisdiction, provided it serves the interest of justice.